Atara Biotherapeutics, Inc.
ATRA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $25 | $26 | $93 | $106 |
| Short-Term Investments | $17 | $26 | $150 | $265 |
| Receivables | $1 | $34 | $40 | $1 |
| Inventory | $11 | $10 | $2 | $0 |
| Other Curr. Assets | $10 | $6 | $10 | $13 |
| Total Curr. Assets | $65 | $102 | $295 | $385 |
| Property Plant & Equip (Net) | $41 | $59 | $74 | $80 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $3 | $5 | $7 | $4 |
| Total NC Assets | $44 | $64 | $81 | $84 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $109 | $166 | $376 | $468 |
| Liabilities | – | – | – | – |
| Payables | $4 | $4 | $7 | $17 |
| Short-Term Debt | $14 | $12 | $14 | $3 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $95 | $78 | $8 | $41 |
| Other Curr. Liab. | $21 | $49 | $50 | $45 |
| Total Curr. Liab. | $135 | $142 | $79 | $106 |
| LT Debt | $30 | $46 | $58 | $26 |
| Deferred Rev, NC | $0 | $38 | $77 | $56 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $42 | $39 | $36 | $2 |
| Total NC Liab. | $72 | $123 | $171 | $83 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $44 | $58 | $72 | $28 |
| Total Liabilities | $206 | $265 | $250 | $189 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$2,055 | -$1,969 | -$1,693 | -$1,465 |
| AOCI | $0 | -$0 | -$2 | -$0 |
| Other Equity | $1,957 | $1,870 | $1,822 | $1,745 |
| Total Equity | -$97 | -$99 | $127 | $280 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $109 | $166 | $376 | $468 |
| Net Debt | $19 | $32 | -$21 | -$78 |